STOCKHOLM, Nov 20 (Reuters) - Anglo-Swedish drugmaker AstraZeneca said on Thursday it would cut 1,400 jobs in the coming years as it revamped its packaging operations. The company said in a statement ...

Amid a corporate review of AstraZeneca’s global manufacturing and supply network, the company’s Indian subsidiary is planning to close up shop at the “beating heart” of its India operations in ...

Moving away from slow-growing markets and pursuing expanding ones, AstraZeneca will trim its U.S. operations and invest in China. The firm has announced that by early December it will eliminate about ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of manufacturing and R&D projects planned over the next five years. The cornerstone of ...

AstraZeneca has signed up life sciences commercialization supporter Indegene to help the British-based Big Pharma with its omnichannel operations. In a nutshell the deal sees Indegene, which is based ...